Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia

European Neuropsychopharmacology

Volumn 10, Issue 5, 2000, Pages 389-395

  Gothelf, Doron ^a   Soreni, Noam ^a   Nachman, Ricardo P ^b   Tyano, Sam ^a   Hiss, Yehuda ^b   Reiner, Orly ^c   Weizman, Abraham ^a  

^a GEHA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Gene expression; Hippocampus; Neuroanatomy; Pathophysiology; Schizophrenia

Indexed keywords

ARTICLE; BRAIN SIZE; CYTOARCHITECTURE; GENE EXPRESSION; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; LIMBIC SYSTEM; MOLECULAR BIOLOGY; NERVE CELL DIFFERENTIATION; NEUROPSYCHOLOGY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0033843278     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(00)00097-3     Document Type: Article

References (65)

1. Adler L.E., Waldo M.C. Counterpoint: A sensory gating-hippocampal model of schizophrenia. Schiz. Bull. 17:1991;19-23.
2. Arnold S.E., Hyman B.T., van Hesen G.W., Damasio A.R. Some cytoarchitectonic disturbances of the entorhinal cortex in schizophrenia. Arch. Gen. Psychiatry. 48:1991;625-632.
3. Arnold S.E., Franz B.R., Gur R.C., Gur R.E., Shapiro R.M., Moberg P.J., Trojanowski J.Q. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am. J. Psychiatry. 152:1995;738-748.
4. Basso M.R., Nasrallah H.A., Olson S.C., Bornstein R.A. Cognitive deficits distinguish patients with adolescent- and adult-onset schizophrenia. Neuropsychiatry Neuropsychol. Behav. Neurol. 10:1997;107-112.
5. Beauregard M., Bachevalier J. Neonatal insult to the hppocampal region and schizophrenia: a review and a putative model. Can. J. Psychiatry. 41:1996;446-456.
6. Benes F.M., Kwok E.W., Vincent S.L., Todtenkopf M.S. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol. Psychiatry. 44:1998;88-97.
7. Bertolino A., Callicott J.H., Elman I., Mattay V.S., Tedesci G., Frank J.A., Breier A., Weinberger D.R. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol. Psychiatry. 43:1998;641-648.
8. Bogerts B., Ashtari M., Degreef G., Alvir J.M., Bilder R.M., Lieberman J.A. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res. 35:1990;1-13.
9. Bogerts B. Recent advances in the neuropathology of schizophrenia. Schizoph. Bull. 19:1993;431-445.
10. Caine S.B., geyer M.A., Swerdlow N.R. Carbachol infusion into the dentate gyrus disrupts sensorimotor gating of the startle reflex in rats. Psychopharmacology. 105:1991;347-354.
11. Chambers R.A., Moore J., McEvoy J.P., Levin E.D. Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. Neuropschopharmacology. 15:1996;587-594.
12. Collinge J., Curtis D. Decrease hippocampal expression of a glutamate receptor gene in schizophrenia. Br. J. Psychiatry. 159:1991;857-859.
13. Conrad A.J., Abebe T., Austin R., Forsythe S., Scheibel A.B. Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomena. Arch. Gen. Psychiatry. 48:1991;413-417.
14. Crow T.J., Ball J., Bloom S.R., Brown R., Bruton C.J., Colter N., Frith C.D., Johnstone E.C., Owens D.G.C., Roberts G.W. Schizophrenia as an anomaly of development of cerebral asymmetry. Arch. Gen. Psychiatry. 46:1989;1145-1150.
15. Davis K.L., Kahn R.S., Ko G., Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiatry. 148:1991;1474-1486.
16. De La Concha A., McKie J., Hodgkinson S., Mankoo B.S., Gurling H.M. Stereospecific effect of flupenthixol on neuroreceptor gene expression. Brain Res. Mol. Brain Res. 10:1991;123-127.
17. DeLisi L.E., Hoff A.L., Schwartz J.E., Shields G.W., Halthore S.N., Gupta S.M., Henn F.A., Anand A.K. Brain morphology in first-episode schizophrenic-like psychotic patients: a quatitative magnetic resonance imaging study. Bio. Psychiatry. 29:1991;159-175.
18. DeLisi L.E., Sakuma M., Tew W., Kushner M., Hoff A.L., Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. Neuroimag. 74:1997;129-140.
19. Deicken R.F., Zhou L., Schuff N., Fein G., Weiner M.W. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy. Biol. Psychiatry. 43:1998;483-488.
20. Deicken R.F., Pegues M., Amend D. Reduced Hippocampal N-Acetylaspartate without volume loss in schizophrenia. Schizophr. Res. 37:1999;217-223.
21. Dwork A.J. Postmortem studies of the hippocampal formation in schizophrenia. Schizophr. Bull. 23:1997;385-402.
22. Eastwood S.L., Burnet P.W., Harrison P.J. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience. 66:1995;309-319.
23. Eastwood S.L., McDonald B., Burnet P.W., Beckwith J.P., Kerwin R.W., Harrison P.J. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. P.J. Brain Res. Mol. Brain Res. 29:1995;211-223.
24. Eastwood S.L., Harrison P.J. Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia. Neuroscience. 86:1998;437-448.
25. Freedman R., Adler L.E., Gerhardt G.A., Waldo M., Baker N., Rose G.M., Nagamoto H., Bickford-Wimer P., Franks R. Neurobiological studies of sensory gating in schizophrenia. Schizopr. Bull. 13:1987;669-678.
26. Freedman R., Hall M., Adler L.E., Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippcampal nicotinic receptors in schizophrenia. Biol. Psychiatry. 38:1995;22-33.
27. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hoff M., et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. USA. 94:1997;587-592.
28. Fukuzako H., Kodama S., Fukuzako T., Yamada K., Hokazono Y., Ueyama K., Hashiguchi T., Takenouchi K., Takigawa M., Takeuchi K., et al. Shortening of the hippocampal formation in first-episode schizophrenic patients. Psychiatry Clin. Neurosci. 49:1995;157-161.
29. Gold J.M., Randolph C., Carpenter C.J., Goldberg T.E., Weinberger D.R. Forms of memory failure in schizophrenia. J. Ab. Psychoalogy. 101:1992;487-494.
30. Goldberg T.E., Torrey E.F., Berman K.F., Weinberger D.R. Relations between neuropsychological performance and brain morphological and physiological measures in monozygotic twins discordant for schizophrenia. Psychiatry Res. 55:1994;51-61.
31. Gur R.E., Mozley P.D., Resnick S.M., Mozley L.H., Shtasel D.L., Gallacher F., Arnold S.E., Karp J.S., Alavi A., Reivich M., Gur R.C. Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia related clinical features. Arch. Gen. Psychiatry. 52:1995;657-667.
32. Heckers S., Rauch S.L., Goff D., Schacter D.L., Fischman A.J., Alpert N.M. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat. Neurosci. 1:1998;318-323.
33. Heinrichs R.W., Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 12:1998;426-445.
34. Isaacson R.L., Pribram K.H. The Hippocampus, Vol. III. 1986;1-63 Plenum Press, New York.
35. Jacobsen L.K., Giedd J.N., Castellanos F.X., Vaituzis A.C., Hamburger S.D., Kumra S., Lenane M.C., Rapoport J.L. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. Am. J. Psychiatry. 155:1998;678-685.
36. Jeste D.V., Lohr J.B. Hippocampal pathologic findings in schizophrenia: a morphometric study. Arch. Gen. Psychiatry. 46:1989;1019-1024.
37. Lehericy S., Dormont D., Semah F., Granat O., Baulac M., Marsault C. Magnetic resonance imaging of temporal lobe epilepsy. J. Radiol. 77:1996;1095-1104.
38. Lipska B.K., Swerdlow N.R., Geyer M.A., Jaskiw G.E., Braff D.L., Weinberger D.R. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology. 122:1995;35-43.
39. Maier M., Ron M.A., Barker G.J., Tofts P.S. Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia. Psychol. Med. 25:1995;1201-1209.
40. Meador-Woodruff J.H., King R.E., Damask S.P., Bovenkerk K.A. Differential regulation of hippocampal AMPA and kainate receptor subunit expression by haloperidol and clozapine. Mol. Psychiatry. 1:1996;41-53.
41. Mishkin M., Appenzeller T. The anatomy of memory. Sci. Am. 256:1987;80-89.
42. Nelson M.D., Saykin A.J., Flashman L.A., Riordan H.J. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch. Gen. Psychiatry. 55:1998;433-440.
43. Nestor P.G., Shenton M.E., Wible C., Hokama H., O'Donnell B.F., Law S., McCarley R.W. A neuropsychological analysis of schizophrenic thought disorder. Schizophr. Res. 29:1998;217-225.
44. Ritter L.M., Meador-Woodruff J.H. Antipsychotic regulation of hippocampal dopamine receptor messenger RNA expression. Biol. Psychiatry. 42:1997;155-164.
45. Saykin A.J., Gur R.C., Gur R.E., Mozley P.D., Mozley L.H., Resnick S.M., Kester D.B., Stafiniak P. Neuropsychological function in schizophrenia: Selective impairment in memory and learning. Arch. Gen. Psychiatry. 48:1991;618-624.
46. Saykin A.J., Shtasel D.L., Gur R.E., Kester D.B., Mozley L.H., Stafinial P., Gur R.C. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch. Gen. Psychiatry. 51:1994;124-131.
47. Seltzer J., Conrad C., Cassens G. Neuropsychological profiles in schizophrenia: paranoid versus undifferentiated distinctions. Schizophr. Res. 7:(23(2)):1997;131-138.
48. Shenton M.E., Kikinis R., Jolesz F.A., Pollak S.D., LeMay M., Wible C.G., Hokama H., Martin J., Metcalf D., Coleman M., McCarley R.W. Abnormalities of the left temporal lobe and thought disorder in schizophrenia: A quantitative magnetic resonance imaging study. New Engl. J. Med. 327:1992;604-612.
49. Silbersweig D.A., Stern E., Frith C., Cahill C., Holmes A., Grootoonk S., Seaward J., McKenna P., Chua S.E., Schnorr L., Jones T., Frackowiak R.S.L. A functional neuroanatomy of hallucinations in schizophrenia. Nature. 378:1995;176-179.
50. Squire L.R., Zola-Morgan S. The medial temporal lobe memory system. Science. 253:1991;1380-1386.
51. Suddath R.L., Christison G.W., Torrey E.F., Casanova M.F., Weinberger D.R. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N. Eng. J. Med. 322:1990;789-794.
52. Swerdlow N.R., Geyer M.A. Using animal model of deficient sensorimotor gating to study the pathophysiology and new treatment of schizophrenia. Schiz. Bull. 24:1998;285-301.
53. Swerdlow N.R., Lipska B.K., Weinberger D.R., Braff D.L., Jaskiw G.E., Geyer M.A. Increased sensitivity to the gating-disruptive effects of apomorphine after lesions of the medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology. 122:1995;27-34.
54. Tamminga C.A., Thaker G.K., Buchanan R., Kirkpatrick B., Alphs L.D., Chase T.N., Carpenter W.T. Limbic system abnormalities identified in schizophrenia using emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch. Gen. Psychiatry. 49:1992;522-530.
55. Torres I.J., Flashman L.A., O'Leary D.S., Swayze I.V., Andreasen N.C. Lack of an association between delayed memory and hippocampal and temporal lobe size in patients with schizophrenia and healthy controls. Biol. Psychiatry. 42:1997;1087-1096.
56. Torrey E.F., Peterson M.R. Schizophrenia and the limbic system. Lancet. 2:1974;942-946.
57. Van Tol H.H.M., Riva M., Civelli O., Creese I. Lack of effect of chronic dopamine blockade on D2 receptor mRNA level. Neurosci. Lett. 11:1990;303-308.
58. Vita A., Bressi S., Perani D., Invernizzi G., Giobbio G.M., Dieci M., Garbarini M., Del Sole A., Fazio F. High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients. Am. J. Psychiatry. 152:1995;876-882.
59. Wexler B.E., Stevens A.A., Bowers A.A., Sernyak M.J., Goldman-Rakic P.S. Word and tone working memory deficits in schizophrenia. Arch. Gen. Psychiatry. 55:1998;1093-1096.
60. Weinberger D.R. Cell biology of the hippocampal formation in schizophrenia. Biol. Psychiatry. 45:1999;395-402.
61. Woods B., Yurgelun-Todd D., Goldstein J.M., Seidman L.J., Tsuang M.T. MRI brain abnormalities in chronic schizophrenia: one process or more? Biol. Psychiatry. 40:1996;585-596.
62. Zaidel D.W., Esiri M.M., Harrison P.J. Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alternations in schizophrenia. Am. J. Psychaitry. 154:1997;812-818.
63. Zaidel D.W., Esiri M.M., Harrison P.J. The hippocampus in schizophrenia: lateralized increase in neuronal denstiy and altered cytoarchitectural asymmetry. Psychol. Med. 27:1997;703-713.
64. Zipursky R.B., Kapur S. New insights into schizophrenia from neuroimaging. Curr. Opin. Psychiatry. 11:1998;33-37.
65. Zola-Morgan S., Squire L.R. Neuroanatomy of memory. Annu. Rev. Neurosci. 16:1993;547-563.